Delivery Order SPE2DB20D7059-SPE2DB25FQCB4

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Erythromycin 250 mg tablets to support government healthcare programs. The $5,148.79 delivery order contract has a firm fixed price and a completion date of October 11, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports defense and healthcare requirements. Amerisourcebergen holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.90, is a delivery order for the procurement of 4567711737 Erythromycin 250 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,254.80, is for the delivery of Erythromycin 250 mg tablets to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This...
This federal contract award is for the delivery of erythromycin tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 27, 2025. The contract has a ceiling value of $1,325.70 and a completion date of January 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of 4,565,040 units of Erythromycin 250 mg tablets to the U.S. Department of Defense (DoD) medical supply chain. The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis. The award, valued at $2,849.87, is a delivery order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,585.35, is for the delivery of 4,567,152,370 units of Erythromycin 250 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,037.43, is for the delivery of 4,563,172,253 units of Erythromycin 250 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 26, 2023. This award is not designated as a set-aside contract....
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of 4,564,402,633 tablets of Erythromycin 250 mg to the agency's facilities. The $6,560.40 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The contract has an ultimate completion date of April 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds a single-award...
This federal contract award, valued at $6,421.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,289,298 units of Erythromycin 250 mg tablets, a critical pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025 for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.82 firm fixed-price delivery order is for the supply of Erythromycin 500 mg tablets to support military treatment facilities and federal healthcare programs. The award is a delivery order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQCB4
    Delivery Order

This federal contract award is for the delivery of Erythromycin 250 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,933.82 and a period of performance through March 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/18/25, 10:45 AM